Cytek Biosciences Appoints Todd Garland Chief Commercial Officer
April 28, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the appointment of Todd Garland as Chief...
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
February 23, 2022 16:05 ET
|
Cytek Biosciences, Inc.
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported...
Cytek to Participate in the 42nd Annual Cowen Health Care Conference
February 16, 2022 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced the company will be participating virtually in the...
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
February 11, 2022 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter...
Cytek® Biosciences Expands Fremont Headquarters, Tripling Its Manufacturing Capacity
January 05, 2022 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has opened a new facility in Fremont,...
Cytek® Biosciences Marks Milestone Achievement with Shipment of 1000th Cell Analysis System
November 17, 2021 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced a significant milestone: the company has shipped...
Cytek Biosciences Reports Third Quarter 2021 Financial Results
November 08, 2021 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the third quarter ended September 30,...
Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
November 03, 2021 08:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has acquired the cell analysis business...
Cytek Biosciences to Report Third Quarter Financial Results on November 8, 2021
October 26, 2021 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter...
Cytek® Biosciences Introduces New 25-Color Immunoprofiling Assay
October 07, 2021 10:00 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- The field of medical research has a new tool to develop vaccines, personal immunotherapies, and cures for cancer and other infectious diseases using...